Track topics on Twitter Track topics that are important to you
PITTSBURGH, Oct. 25, 2017 (GLOBE NEWSWIRE) Read more...
Last year while driving across the country, I made a slight detour northward to visit the city of Moscow, Idaho. I met up with Professor Shelley McGuire at Washington State University and two other me...
SACRAMENTO >> Despite an intense lobbying effort by the pharmaceutical industry, State Senator Mike McGuire's legislation that restricts pharmaceutical companies from giving gifts and incent...
The FDA has granted expedited access pathway designation to Second Sight Medical Products for its Orion cortical visual prosthesis system, according to a company press release.The designation, given t...
Second Sight Medical Products announced the Medicare hospital outpatient payment rate for 2018 for the Argus II retinal prosthesis system procedure, according to a company press release.CMS finalized ...
Acceleron Pharma Inc. (NASDAQ:XLRN) today announced the appointment of the experienced biopharmaceutical executive, Karen Smith, M.D., Ph.D., to its board of directors and the de...
Experiences from the clinical setting are ideal for building critical thinking skills if reflection is used as a teaching tool. Reflective writing is the purposeful and recurring inspection of thought...
We have published hundreds of McGuire Sponsel news stories on BioPortfolio along with dozens of McGuire Sponsel Clinical Trials and PubMed Articles about McGuire Sponsel for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of McGuire Sponsel Companies in our database. You can also find out about relevant McGuire Sponsel Drugs and Medications on this site too.